Services / Cancer Care / Research / Clinical Trials /

Clinical Trial

« Back to List

SUP 01

Posted by: Fred J. Kudrik, MD, Principal Investigator | Posted Date: December 31, 2012

Status: OPEN-IST 
Research Hotline: 

Details: A Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled Study of the Safety and Efficacy of Rolapitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Subjects Receiving Moderately Emetogenic Chemotherapy (MEC).

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share